Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,665 | 571 | 96.8% |
| Education | $322.66 | 5 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,820 | 112 | $0 (2024) |
| PFIZER INC. | $1,348 | 77 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,027 | 64 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $839.81 | 33 | $0 (2024) |
| LEO Pharma Inc. | $769.20 | 47 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $707.48 | 43 | $0 (2024) |
| Janssen Biotech, Inc. | $531.12 | 38 | $0 (2022) |
| Amgen Inc. | $482.47 | 25 | $0 (2024) |
| GENZYME CORPORATION | $471.70 | 23 | $0 (2024) |
| Lilly USA, LLC | $330.98 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,008 | 51 | LEO Pharma Inc. ($234.37) |
| 2023 | $859.61 | 43 | PFIZER INC. ($233.66) |
| 2022 | $1,436 | 74 | ABBVIE INC. ($406.60) |
| 2021 | $1,214 | 78 | AbbVie Inc. ($320.11) |
| 2020 | $700.36 | 39 | Amgen Inc. ($107.72) |
| 2019 | $1,811 | 107 | Novartis Pharmaceuticals Corporation ($256.86) |
| 2018 | $1,598 | 105 | AbbVie, Inc. ($187.53) |
| 2017 | $1,362 | 79 | LEO Pharma Inc. ($235.89) |
All Payment Transactions
576 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Inflammation & Immunology | ||||||
| 12/03/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Inflammation & Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: DERMATOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Inflammation & Immunology | ||||||
| 09/03/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: DERMATOLOGY | ||||||
| 08/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: DERMATOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: DERMATOLOGY | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Dermatology | ||||||
| 07/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: DERMATOLOGY | ||||||
| 07/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: DERMATOLOGY | ||||||
| 06/27/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,789 | 3,166 | $321,487 | $147,035 |
| 2022 | 12 | 1,836 | 3,455 | $305,731 | $162,556 |
| 2021 | 17 | 2,050 | 4,821 | $363,147 | $205,138 |
| 2020 | 16 | 1,777 | 3,540 | $293,263 | $160,632 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 433 | 530 | $107,600 | $52,787 | 49.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 221 | 342 | $63,690 | $29,458 | 46.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 320 | 420 | $45,585 | $16,960 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 194 | $27,948 | $14,124 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $16,912 | $8,077 | 47.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 176 | 203 | $17,874 | $7,802 | 43.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 242 | 1,212 | $13,191 | $6,448 | 48.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 65 | 71 | $11,830 | $4,621 | 39.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $6,445 | $2,753 | 42.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,149 | $1,911 | 46.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 27 | 35 | $3,223 | $1,344 | 41.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $2,016 | $718.85 | 35.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 41 | $1,025 | $31.08 | 3.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 512 | 749 | $129,890 | $74,155 | 57.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 242 | 352 | $56,112 | $29,534 | 52.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 330 | 433 | $40,375 | $17,740 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $18,951 | $9,669 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 131 | $16,103 | $8,217 | 51.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 157 | 184 | $14,186 | $7,884 | 55.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 254 | 1,342 | $12,729 | $7,148 | 56.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 61 | 63 | $9,090 | $4,557 | 50.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 26 | 41 | $3,229 | $1,606 | 49.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,278 | $1,210 | 53.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $1,688 | $801.28 | 47.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 26 | 44 | $1,100 | $34.66 | 3.2% |
About Dr. Robert Ecker, MD
Dr. Robert Ecker, MD is a Dermatology healthcare provider based in Groton, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811950074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ecker, MD has received a total of $9,988 in payments from pharmaceutical and medical device companies, with $1,008 received in 2024. These payments were reported across 576 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($9,665).
As a Medicare-enrolled provider, Ecker has provided services to 7,452 Medicare beneficiaries, totaling 14,982 services with total Medicare billing of $675,361. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Groton, CT
- Active Since 04/10/2006
- Last Updated 11/25/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1811950074
Products in Payments
- EUCRISA (Drug) $1,211
- COSENTYX (Biological) $736.47
- DUPIXENT (Biological) $729.96
- SKYRIZI (Biological) $708.39
- Humira (Biological) $601.94
- DUPIXENT (Drug) $435.46
- ENSTILAR (Drug) $401.04
- ADBRY (Biological) $341.65
- TALTZ (Drug) $330.98
- RINVOQ (Biological) $305.70
- Enbrel (Biological) $303.12
- TREMFYA (Drug) $257.34
- Tremfya (Drug) $256.04
- DUPIXENT DUPILUMAB INJECTION (Biological) $246.08
- DUOBRII (Drug) $225.82
- ILUMYA (Biological) $220.26
- Otezla (Drug) $210.52
- Cimzia (Drug) $142.74
- HUMIRA (Biological) $140.26
- JUBLIA (Drug) $138.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.